Literature DB >> 24201195

Draft Genome Sequence of the Clinical Isolate Acinetobacter nosocomialis Strain M2.

Michael D Carruthers1, Christian M Harding, Beth D Baker, Robert A Bonomo, Kristine M Hujer, Philip N Rather, Robert S Munson.   

Abstract

We report the 3.78-Mbp high-quality draft assembly of the genome from a clinical isolate of Acinetobacter nosocomialis called strain M2 (previously known as Acinetobacter baumannii strain M2).

Entities:  

Year:  2013        PMID: 24201195      PMCID: PMC3820776          DOI: 10.1128/genomeA.00906-13

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Acinetobacter nosocomialis is a member of the Acinetobacter calcoaceticus-Acinetobacter baumannii (ACB) complex, which is composed of A. calcoaceticus, A. baumannii, Acinetobacter pittii (formerly genomic species 3), and A. nosocomialis (formerly genomic species 13 TU) (1). Except for A. calcoaceticus, members of the ACB complex are opportunistic pathogens that pose a significant threat to human health through their ability to cause severe infections. This threat is compounded by both the high incidence of ACB complex infections in critically ill patients and the prevalence of antibiotic resistance exhibited by members of the ACB complex (2). A. nosocomialis strain M2, isolated in 1996 from a hip infection of a patient at Cleveland MetroHealth Systems (Cleveland, OH), has been studied in several laboratories. An acyl-homoserine lactone autoinducer synthase from strain M2 has been isolated and characterized (3). Nonnative acyl-homoserine lactones have been shown to attenuate strain M2 quorum sensing (4). A novel mechanism of fluoroquinolone resistance has been discovered through the mutagenesis of strain M2 (5). The twitching motility exhibited by strain M2 is mediated by a type IV pilus system, which also mediates the natural transformation phenotype of strain M2 (6). Strain M2 is also motile on the surface of agar plates through an unknown (7) Tfp-independent mechanism (6). In addition, strain M2 is able to outcompete other bacteria using a type VI secretion system (8). Genomic DNA was prepared using the Qiagen DNA purification kit. Genome sequencing was performed using the Illumina HiSeq and MiSeq platforms maintained at the Research Institute at Nationwide Children’s Hospital Biomedical Genomics Core (http://genomics.nchresearch.org). A total of 4 million paired-end MiSeq reads (300-bp insert size) trimmed to 200 bp and 4 million mate-pair HiSeq reads (3-kb insert size) trimmed to 35 bp were assembled de novo using SeqMan NGen (version 4.1.2; DNAStar, Madison, WI). Postassembly manipulation was performed using SeqMan Pro (DNAStar). This genome assembly yielded 11 contigs comprising a total genome length of 3,782,411 bp and an N50 of 556 kb, with 163-fold average coverage. Genome annotation using the NCBI Prokaryotic Genomes Automatic Annotation Pipeline (version 2.0) predicted a total of 3,487 open reading frames. Previously, strain M2 was classified by multilocus sequence typing (MLST) as belonging to the A. baumannii species (R. A. Bonomo, unpublished data). Two currently available MLST schemes were used to retype strain M2. Four of the seven genes required for MLST using the “Oxford” scheme (see http://pubmlst.org) were identified in the M2 genome. Based upon this analysis, strain M2 is most closely related to an Acinetobacter sp. 13TU isolate from Brazil. Five of the eight genes required for MLST using the “Pasteur” scheme (see http://www.pasteur.fr/mlst) were identified in the strain M2 genome. An analysis of these alleles indicates that strain M2 is most closely related to Acinetobacter sp. 13TU strain RUH 2210. Based on this evidence, we recommend that A. baumannii strain M2 be referred to as A. nosocomialis strain M2.

Nucleotide sequence accession numbers.

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession no. AWOW00000000. The version described in this paper is version AWOW01000000.
  9 in total

1.  Novel mechanism for fluoroquinolone resistance in Acinetobacter baumannii.

Authors:  Sunil D Saroj; Katy M Clemmer; Robert A Bonomo; Philip N Rather
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

2.  Genetic analysis of surface motility in Acinetobacter baumannii.

Authors:  Katy M Clemmer; Robert A Bonomo; Philip N Rather
Journal:  Microbiology (Reading)       Date:  2011-06-23       Impact factor: 2.777

3.  Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU).

Authors:  Alexandr Nemec; Lenka Krizova; Martina Maixnerova; Tanny J K van der Reijden; Pieter Deschaght; Virginie Passet; Mario Vaneechoutte; Sylvain Brisse; Lenie Dijkshoorn
Journal:  Res Microbiol       Date:  2011-02-12       Impact factor: 3.992

4.  Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii.

Authors:  Chen Niu; Katy M Clemmer; Robert A Bonomo; Philip N Rather
Journal:  J Bacteriol       Date:  2008-02-15       Impact factor: 3.490

Review 5.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

6.  Attenuation of quorum sensing in the pathogen Acinetobacter baumannii using non-native N-Acyl homoserine lactones.

Authors:  Danielle M Stacy; Michael A Welsh; Philip N Rather; Helen E Blackwell
Journal:  ACS Chem Biol       Date:  2012-08-14       Impact factor: 5.100

7.  BIGSdb: Scalable analysis of bacterial genome variation at the population level.

Authors:  Keith A Jolley; Martin C J Maiden
Journal:  BMC Bioinformatics       Date:  2010-12-10       Impact factor: 3.169

8.  Acinetobacter baumannii utilizes a type VI secretion system for bacterial competition.

Authors:  Michael D Carruthers; Paul A Nicholson; Erin N Tracy; Robert S Munson
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

9.  Acinetobacter baumannii strain M2 produces type IV pili which play a role in natural transformation and twitching motility but not surface-associated motility.

Authors:  Christian M Harding; Erin N Tracy; Michael D Carruthers; Philip N Rather; Luis A Actis; Robert S Munson
Journal:  mBio       Date:  2013-08-06       Impact factor: 7.867

  9 in total
  21 in total

Review 1.  Role of quorum sensing in bacterial infections.

Authors:  Israel Castillo-Juárez; Toshinari Maeda; Edna Ayerim Mandujano-Tinoco; María Tomás; Berenice Pérez-Eretza; Silvia Julieta García-Contreras; Thomas K Wood; Rodolfo García-Contreras
Journal:  World J Clin Cases       Date:  2015-07-16       Impact factor: 1.337

2.  KatG and KatE confer Acinetobacter resistance to hydrogen peroxide but sensitize bacteria to killing by phagocytic respiratory burst.

Authors:  Daqing Sun; Sara A Crowell; Christian M Harding; P Malaka De Silva; Alistair Harrison; Dinesh M Fernando; Kevin M Mason; Estevan Santana; Peter C Loewen; Ayush Kumar; Yusen Liu
Journal:  Life Sci       Date:  2016-02-06       Impact factor: 5.037

3.  Structural Diversity in the Type IV Pili of Multidrug-resistant Acinetobacter.

Authors:  Kurt H Piepenbrink; Erik Lillehoj; Christian M Harding; Jason W Labonte; Xiaotong Zuo; Chelsea A Rapp; Robert S Munson; Simeon E Goldblum; Mario F Feldman; Jeffrey J Gray; Eric J Sundberg
Journal:  J Biol Chem       Date:  2016-09-15       Impact factor: 5.157

4.  A multidrug resistance plasmid contains the molecular switch for type VI secretion in Acinetobacter baumannii.

Authors:  Brent S Weber; Pek Man Ly; Joshua N Irwin; Stefan Pukatzki; Mario F Feldman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

Review 5.  Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond.

Authors:  Brent S Weber; Christian M Harding; Mario F Feldman
Journal:  J Bacteriol       Date:  2015-12-28       Impact factor: 3.490

6.  Pathogenic Acinetobacter species have a functional type I secretion system and contact-dependent inhibition systems.

Authors:  Christian M Harding; Marina R Pulido; Gisela Di Venanzio; Rachel L Kinsella; Andrew I Webb; Nichollas E Scott; Jerónimo Pachón; Mario F Feldman
Journal:  J Biol Chem       Date:  2017-04-03       Impact factor: 5.157

7.  Pilus Production in Acinetobacter baumannii Is Growth Phase Dependent and Essential for Natural Transformation.

Authors:  Nina Vesel; Melanie Blokesch
Journal:  J Bacteriol       Date:  2021-03-23       Impact factor: 3.490

8.  Staphylococcus aureus and Acinetobacter baumannii Inhibit Osseointegration of Orthopedic Implants.

Authors:  Hyonmin Choe; Joscelyn M Tatro; Bryan S Hausman; Kristine M Hujer; Steve H Marshall; Ozan Akkus; Phillip N Rather; Zhenghong Lee; Robert A Bonomo; Edward M Greenfield
Journal:  Infect Immun       Date:  2022-01-31       Impact factor: 3.609

9.  Identification of genes essential for pellicle formation in Acinetobacter baumannii.

Authors:  Sarah K Giles; Uwe H Stroeher; Bart A Eijkelkamp; Melissa H Brown
Journal:  BMC Microbiol       Date:  2015-06-06       Impact factor: 3.605

10.  Acinetobacter baumannii Virulence Is Mediated by the Concerted Action of Three Phospholipases D.

Authors:  Julia Stahl; Holger Bergmann; Stephan Göttig; Ingo Ebersberger; Beate Averhoff
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.